Local artery blocking device cuts knee osteoarthritis pain by 57%, study reveals

NextBiomedical's fast-resorbable microspheres, Nexsphere-F lowered knee osteoarthritis pain in a study on standard treatment non-responders. By blocking pro-inflammatory, abnormal blood vessels in the knee, Nexsphere-F improved patient outcomes and diminished osteoarthritis pain. Researchers estimate that knee osteoarthritis impacts around 7.6% of the global population. Credit: Ton Photographer 4289 / Shutterstock.com. NextBiomedical’s artery-blocking device, Nexsphere-F, has significantly improved outcomes in patients with knee osteoarthritis in a European clinical study – a move the company says takes it closer to establishing the solution as a standard of care (SoC) in genicular artery embolisation (GAE). During a prospective observational study conducted by researchers…

Source: Clinical Trials Arena